Introduction
Azolemycins A-D are compounds recently isolated from the soil bacterium, Streptomyces sp. FXJ1.264.
1 A combination of mass spectrometry and 1D and 2D NMR spectrometry identified the 10 structure as a modified heptapeptide, with four linked azoles and an N-terminal oxime. The major isolated azolemycins are the Nhydroxy derivative with the greater proportion as the E-oxime geometric isomer 1a, named azolemycin A and the lesser proportion as the Z-geometric isomer 1b, named azolemycin B 15 ( Fig. 1) . The minor isolated azolemycins differ only in containing an N-methoxy group and again were isolated as the E-isomer 2a and the Z-isomer 2b (azolemycins C and D respectively). The biosynthesis of the azolemycins has been described, 1 and is believed to involve the posttranslational modification of a ribosomally-biosynthesised 7 amino-acid precursor. The oxime functional group is believed to occur from a previously unknown 25 posttranslational modification, apparently utilizing a flavindependent monooxygenase to catalyse the oxidation of an Nterminal valine residue to the corresponding oxime.
1 Oximecontaining natural products are unusual, and those reported, including caerulomycin A, althiomycin, collismycin A and 30 nocardicins A and B, 2 result from nonribosomal peptide synthesis.
Until the 1980s, very few thiazole and oxazole-containing natural products were known, but an increasing array have since been identified, particularly derived from marine sources. 11a The disconnection gave four distinct units: the isopropyl oxime 3, the left-hand mixed bisoxazole fragment 4, the right-hand methyl oxazole 5 and the isoleucine methyl ester 6 55 (figure 2).
Figure 2
Preliminary disconnections for the synthesis of azolemycin A As we planned to synthesise the thiazole from serine, the 60 tetraazole core could be divided into two repeating serinethreonine dimers, corresponding to a common threonine derived oxazole 5. We therefore further disconnected the AB unit 4 into oxazole 8 and Boc-L-valine, 7 (figure 2). The protected oxazole building block 5 was synthesised from the diprotected Boc-serine acetonide 10. An HOBt/EDCI peptide coupling gave the threonine dipeptide 11 in excellent yields. Oxidation of the threonine residue using the Parikh-Doering conditions, 12 and cyclodehydration using PPh3/I2/NEt3, as described by Wipf, 7c 5 gave the oxazole 5 (scheme 1). In some reaction batches some unreacted alcohol 11 was carried through, with ketone 12, to the cyclodehydration step. In these cases, the elimination product 13 was obtained and this was extremely difficult to separate from oxazole 5. We therefore performed a Sharpless dihydroxylation 10 on the mixture of alkene 13 and oxazole 5. 13 This chemoselective procedure did not affect the oxazole but, as predicted, a simple aqueous work-up afforded only the clean oxazole 5. We propose that the alkene 13 formed an unstable diol that decomposed to give two non-isolated water soluble products, an amide and a 15 keto-ester.
Scheme 1 (i) Dimethoxypropane, TsOH.H2O, CH2Cl2, 40°C, 2 h, 80 %; (ii) l-Thr.OMe.HCl, EDCI, cat. HOBt, EtOH, 0°C to rt, 18 h, 84 %; (iii) SO3.pyr, DMSO, i Pr2EtN, CH2Cl2, 0°C, 3 h; (iv) PPh3, I2, NEt3, CH2Cl2, 0°C to rt, 18 h, 32 % over 2 steps; (v) 20 AcCl, MeOH, rt, 18h, quant
The AB unit was formed from the tripeptide 14, which was made by coupling Boc-valine 7 to the deblocked oxazole-amine 8 (scheme 2). The serine residue was then cyclodehydrated using DAST to give the crude oxazoline, as described by Williams et 25 al. in their synthesis of (-)-hennoxazole A. 6a . Attempts to oxidise this using standard conditions (e.g. BrCCl3 and DBU, 5f or BrCCl3, CCl4 and pyridine 14 ) were unsuccessful, presumably due to the unactivated nature of the oxazoline. Though oxidations of this type of relatively unactivated oxazoline are not common in 30 the literature, examples do exist which use either MnO2 or NiO2, 5i, 11c, 11d which are assumed to follow a similar mechanism.
15 Despite being a widely used oxidising agent, many procedures do not state the provenance or preparation method of MnO2, and the method of preparation has been shown to have a 35 significant effect on the oxidative ability of the reagent. 16 Yokokawa and Shioiri have reported that chemical manganese dioxide (CMD), manufactured for the production of dry batteries, is a superior oxidising agent than MnO2 prepared by other methods. 17 We therefore investigated a method of producing 40 activated MnO2 proposed by Ball, Goodwin and Morton, where an aqueous solution of potassium permanganate is reacted with manganese sulfate in neutral medium to give a precipitate of MnO2. 18 The MnO2 is then activated as required by azeotropic drying with toluene, as described by Goldman. 19 This provides a 45 source of MnO2 presumably similar in composition to the CMD, and indeed a similar technique using benzene-dried CMD was successfully exploited by Shioiri and Yokokawa for the synthesis of a variety of thiazole-containing natural products.
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The oxazoline was treated with an excess of the freshly 50 activated MnO2 and, on completion, the residual MnO2 was reduced using aqueous SO2. A simple aqueous work-up and silica chromatography gave the clean bisoxazole 4 in 27 % yield over two steps. It is likely that loss of the N-terminal Boc group during the reduction of the MnO2 cause the low yield for this step, and a 55 more resilient protecting group would undoubtedly have improved the yield. As this step provided us with sufficient material to complete the synthesis however, we did not attempt to optimise it further. One major concern was retaining the stereointegrity of the N-terminal valine during oxazole synthesis.
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Previous work within the group had identified isoleucine as a useful residue to detect epimerization by 1 H NMR in similar reactions. Boc-Ile-Ser-OMe was used as a model compound for oxazole, and we were encouraged to see no apparent epimerization of the N-terminal stereocentre (see ESI).
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Scheme 2 (i) 7, EDCI, cat. HOBt, NMM, EtOH, rt, 18 h, 88 %; (ii) DAST, CH2Cl2, -78°C to rt 2 h; then MnO2, toluene, 110°C, 6 h, 27 %.
Methyl ester 4 was hydrolysed, and the resulting acid 70 underwent an EDCI/HOBt coupling with amine 8 to give the pentapeptide, 15. Protection of the pendant alcohol to give 16 was required to prevent beta-elimination during the formation of the thioamide, which was achieved in excellent yields with Lawesson's reagent to give 17. Deprotection of the alcohol 75 provided 18, which underwent for a further DAST mediated cyclodehydration to give the crude thiazoline. This was oxidised using CCl4 and pyridine to give thiazole 19 in a 27 % yield over 5 steps (scheme 3). With the synthesis of the four azoles achieved, the completion of the natural products could be attempted. Saponification of the methyl ester 19 was more difficult than expected due to its low solubility, but long reaction times, high dilution and a mixture of solvents provided the hydrolysis product 20, which was readily 5 coupled to isoleucine methyl ester to give the hexapeptide 21. Removal of the Boc-protecting group allowed coupling 2-hydroxy-3-methylbutyric acid 22, made from L-valine according to the method of Bauer and Gajewiak, 21 to give alcohol 23. This alcohol was oxidised to the ketone 24 which was reacted with 10 hydroxylamine to give azolemycin A, 1a (scheme 4; 21 steps, 16 steps longest linear sequence, with an overall yield of 0.3 %). Reaction of ketone 24 with methoxyamine gave azolemycin D, 2b, with a similar yield.
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Scheme 4, MeOH, THF, CH2Cl2, H2O, rt, 26 h, 92 %; (ii) L-IleOMe.HCl, EDCI, cat. HOBt, NMM, EtOH, rt, 18 h, 84 %; (iii) NaNO2, H2SO4, H2O, 0°C to rt, 18 h, 31 %; (iv)a) MeOH, AcCl,rt, 2 h; b) 22, EDCI, cat. HOBt, NMM, EtOH, 0°C to rt, 18 h, 90 % over 2 steps; (v) SO3.pyr., NEt3.DMSO, CH2Cl2, 0°C, 3 20 h, 65 %; (vi) NH2OH.HCl, pyridine, MeOH, CH2Cl2, rt, 24 h, 58 %; (vii) NH2OMe.HCl, pyridine, MeOH, CH2Cl2, rt, 4h, 62 %.
The 1 H NMR spectra of the two synthesized natural products correlate well with the spectra of the naturally derived molecules. However, while the naturally derived azolemycins were isolated 25 separately as both the E-and Z-oxime isomers, a separation was not possible for the synthesized product, 1. The synthetic product consisted mainly of the E-oxime 1a (azolemycin A), with only traces of the Z-isomer 1b (azolemycin B), based on the valine α-CH peaks in 1 H NMR spectra. In contrast, the synthetic N-30 methoxy azolemycins, 2, were obtained as primarily the Zgeometric oxime isomer (azolemycin D), but in CDCl3 showed near complete conversion to the E-isomer (azolemycin C) in around 5 days.
To extend this project, the synthesis of an azolemycin-like 35 tetra-oxazole natural product analogue 30 was attempted. It was envisaged that any activity shown by the natural product azolemycin A could be compared with this tetraoxazole equivalent to observe the requirement, if any, for the C-ring thiazole. The synthesis of 30 was achieved in a straightforward 40 fashion by cyclisation and oxidation of serine-derived precursor 15, forming the C-ring oxazole (scheme 5). This internal oxazole was formed with comparative ease compared to the N-terminal oxazole A in the bisoxazole fragment 4. This supports our hypothesis that, while an adjacent electron withdrawing group at 45 the 4-position is important for the oxidation of oxazolines, the reaction will still proceed in excellent yields if the forming benefits from conjugation at the 2-and 4-positions with neighbouring azoles. NMR spectrometry suggests that oxime 30 was formed as a mixture with the Z-isomer as the major isomer, with the major peak in the 1H spectrum for the CH adjacent to the oxime at 3.00 60 ppm, and the minor peak at 3.49 ppm (compare with 3.50 ppm for E-1a, 3.00 ppm for Z-1b). Comparison of the 13 C NMR spectra of the tetraoxazole 30 with the equivalent synthesized azolemycin A 1 showed some distinctive differences. As well as the obvious shift of the peak corresponding to C32 from 120.2 65 ppm in 1 to 138.31 ppm in 30, the peaks corresponding to the other carbons of azole C, and those immediately surrounding it, were shifted significantly. In particular, in the thiazole 1 the peak corresponding to B ring carbon C11, occurs at 130.9 ppm, but in the oxazole 30 the C11 peak appears at 125.7 ppm. This large difference in chemical shift may facilitate the identification of the relative positions of oxazoles and thiazoles in new polyazole natural products.
Figure 5
Numbering for azolemycin A, 1 and tetraoxazole 30.
These syntheses produced azolemycin A and C and the tetraoxazole analogue 30, for initial biological testing. 1 We are continuing assays in this area.
